Evidence map›Paper›PMID 37504218›Full record

ArticleACS nano2023

Correction to "Nanocarrier Co-formulation for Delivery of a TLR7 Agonist plus an Immunogenic Cell Death Stimulus Triggers Effective Pancreatic Cancer Chemo-immunotherapy".

Lijia Luo, Xiang Wang, Yu-Pei Liao, Chong Hyun Chang, Andre E Nel

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lijia LuoDivision of Nanomedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States.ORCID 0000-0001-7125-6562
Xiang WangDivision of Nanomedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States.ORCID 0000-0002-6647-0684
Yu-Pei LiaoDivision of Nanomedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States.ORCID 0000-0001-7239-9426
Chong Hyun ChangCalifornia NanoSystems Institute, University of California, Los Angeles, California 90095, United States.
Andre E NelDivision of Nanomedicine, Department of Medicine, University of California, Los Angeles, California 90095, United States.ORCID 0000-0002-5232-4686
California NanoSystems Institute · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37504218
OpenAlexW4385330399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.